-
From 'flop' to Super Bowl favorite: Sam Darnold's second act
-
Man sentenced to life in prison for plotting to kill Trump in 2024
-
Native Americans on high alert over Minneapolis crackdown
-
Dallas deals Davis to Wizards in blockbuster NBA deal: report
-
Russia 'no longer bound' by nuclear arms limits as treaty with US ends
-
Panama hits back after China warns of 'heavy price' in ports row
-
Strike kills guerrillas as US, Colombia agree to target narco bosses
-
Wildfire smoke kills more than 24,000 Americans a year: study
-
Telegram founder slams Spain PM over under-16s social media ban
-
Curling kicks off sports programme at 2026 Winter Olympics
-
Preventative cholera vaccination resumes as global supply swells: WHO
-
Wales' Macleod ready for 'physical battle' against England in Six Nations
-
Xi calls for 'mutual respect' with Trump, hails ties with Putin
-
'All-time great': Maye's ambitions go beyond record Super Bowl bid
-
Shadow over Vonn as Shiffrin, Odermatt headline Olympic skiing
-
US seeks minerals trade zone in rare Trump move with allies
-
Ukraine says Abu Dhabi talks with Russia 'substantive and productive'
-
Brazil mine disaster victims in London to 'demand what is owed'
-
AI-fuelled tech stock selloff rolls on
-
Russia vows to act 'responsibly' as nuclear pact ends with US
-
White says time at Toulon has made him a better Scotland player
-
Washington Post announces 'painful' job cuts
-
All lights are go for Jalibert, says France's Dupont
-
Artist rubs out Meloni church fresco after controversy
-
Palestinians in Egypt torn on return to a Gaza with 'no future'
-
US removing 700 immigration officers from Minnesota
-
Who is behind the killing of late ruler Gaddafi's son, and why now?
-
Coach Thioune tasked with saving battling Bremen
-
Russia vows to act 'responsibly' once nuclear pact with US ends
-
Son of Norway's crown princess admits excesses but denies rape
-
US calls for minerals trade zone in rare move with allies
-
Vowles dismisses Williams 2026 title hopes as 'not realistic'
-
'Dinosaur' Glenn chasing skating gold in first Olympics
-
Gaza health officials say strikes kill 23 after Israel says shots wounded officer
-
Italy foils Russian cyberattacks targeting Olympics
-
Stocks stabilise after Wall St AI-fuelled sell-off
-
Figure skating favourite Malinin feeling 'the pressure' in Milan
-
Netflix film probes conviction of UK baby killer nurse
-
Timber hopes League Cup can be catalyst for Arsenal success
-
China calls EU 'discriminatory' over probe into energy giant Goldwind
-
Sales warning slams Ozempic maker Novo Nordisk's stock
-
Can Vonn defy ACL rupture to win Olympic medal?
-
Breakthrough or prelude to attack? What we know about Iran-US talks
-
German far-right MP detained over alleged Belarus sanctions breach
-
MSF says its hospital in South Sudan hit by government air strike
-
Merz heads to Gulf as Germany looks to diversify trade ties
-
Selection process for future Olympic hosts set for reform
-
Serbian minister on trial over Trump-linked hotel plan
-
UK PM says Mandelson 'lied', regrets appointing him US envoy
-
Cochran-Siegle tops first Olympic downhill training
| CMSD | -0.25% | 23.88 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| CMSC | -0.51% | 23.54 | $ | |
| BCC | 5.97% | 90.32 | $ | |
| RIO | -0.05% | 96.32 | $ | |
| JRI | 0.04% | 13.125 | $ | |
| RBGPF | 0.12% | 82.5 | $ | |
| BCE | 1.08% | 26.385 | $ | |
| RYCEF | -2.41% | 16.6 | $ | |
| NGG | 2.36% | 88.31 | $ | |
| RELX | -1.8% | 29.97 | $ | |
| BTI | -0.11% | 61.805 | $ | |
| GSK | 7.09% | 57.41 | $ | |
| AZN | 1.92% | 187.92 | $ | |
| VOD | 2.96% | 15.715 | $ | |
| BP | 1.01% | 39.215 | $ |
No-prescription birth control pills soon available in US pharmacies
Prescription-free birth control pills will be available across the United States later this month, widening access to contraception at a time when abortion rights have been drastically curtailed.
American-Irish maker Perrigo Company announced Monday that its Opill has "shipped to major retailers and pharmacies and will be available on shelves nationwide," available in one-month and three-month packs for $19.99 and $49.99 respectively. It will also be available on Opill.com.
Over-the-counter (OTC) birth control has long been backed by major medical organizations as a way to reduce barriers to contraception access, with more than 6.1 million births in the US each year unintended, according to official data.
"We champion the right of women and people to determine their own sexual health journey and the availability of Opill over-the-counter is truly a historic moment of which our entire organization can be proud," said Perrigo Executive Vice President Triona Schmelter.
Opill, which was cleared last year by the Food and Drug Administration for sale without prescription, is known as a "mini pill" because it contains progestin only, and works by thickening mucus in the cervix to stop sperm reaching an egg.
Preserving access to contraception has proven politically divisive following the conservative-led Supreme Court's decision to revoke the national right to abortion in 2022.
Twenty-one states banned or moved to restrict abortions to limits tighter than before Roe v Wade, the case law that previously upheld the constitutional right to terminate a pregnancy.
Republicans in Congress also blocked Democrat-backed legislation that would have codified individuals' right to access contraception, an issue that has taken on more urgency as conservative-run states define personhood in new ways.
Alabama's top court last month said that frozen embryos should be considered children, though the state's legislature quickly moved to pass a bill protecting clinics from legal liability if such embryos were inadvertently damaged or destroyed.
Over-the-counter birth control is backed by major medical organizations, including the American College of Obstetricians and Gynecologists (ACOG), the American Medical Association and the American Academy of Family Physicians.
Much of Asia, Africa and Latin America allow OTC birth control. The UK joined the club in 2021, but prescriptions are still required in much of mainland Europe including France, Germany, Spain and Italy, according to "Free the Pill" which tracks the issue.
B.Shevchenko--BTB